FDA Drug Recalls

Recalls / Class II

Class IID-0419-2021

Product

Rectiv (nitroglycerin) Ointment 0.4% For Intra-anal Use Only 30 g Rx Only NDC 58914-301-80 Mfd. by: Pharbil Waltrop GmbH, Im Wirrigen 25, 45731 Waltrop, Germany Distributed by: Aptalis Pharma US, Inc. Birmingham, AL 35242

Brand name
Rectiv
Generic name
Nitroglycerin
Active ingredient
Nitroglycerin
Route
Rectal
NDC
58914-301
FDA application
NDA021359
Affected lot / code info
2399070

Why it was recalled

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Recalling firm

Firm
Cardinal Health Inc.
Manufacturer
Allergan, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7000 Cardinal Pl, N/A, Dublin, Ohio 43017-1091

Distribution

Quantity
31 tubes
Distribution pattern
FL, GA, SC

Timeline

Recall initiated
2021-03-15
FDA classified
2021-05-24
Posted by FDA
2021-06-02
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0419-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Rectiv · FDA Drug Recalls